Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71785-1008

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71785-1008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Annora Pharma Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A pharmacokinetic interaction chart for venlafaxine showing fold changes in Cmax and AUC relative to reference values when co-administered with various interacting drugs such as ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The chart includes 90% confidence intervals and provides clinical recommendations for use or dose adjustment based on these interactions.*

FDA Label Image

Figure2 (Figure2)

A forest plot chart showing PKFold change and 90% confidence intervals for various interacting drugs' Cmax and AUC analytes relative to a reference value. The chart includes annotations indicating dosage adjustment recommendations or clinical significance for drugs like ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium.*

FDA Label Image

Figure3 (Figure3)

A data table showing pharmacokinetic fold changes and 90% confidence intervals for venlafaxine in various special populations, including hepatic impairment, renal impairment, CYP2D6 polymorphism, age, and gender. The table includes analytes, pharmacokinetic parameters (Cmax, AUC), and dose adjustment recommendations based on observed changes relative to reference values.*

FDA Label Image

Venlafaxinecap150mgblistercarton (Venlafaxinecap150mgblistercarton)

Packaging label for Venlafaxine Hydrochloride Extended-Release Capsules USP, 150 mg, manufactured by Annora Pharma Private Limited. The label states this is an Rx-only oral capsule in unit-dose format with 100 capsules (10 x 10). Storage instructions specify 20° to 25°C. The label includes the NDC 71785-1008-3 and a note for pharmacists to dispense the medication guide separately.*

FDA Label Image

Venlafaxinecap150mgcontlabel30s (Venlafaxinecap150mgcontlabel30s)

Label for Venlafaxine Hydrochloride Extended-Release Capsules USP 150 mg by Annora Pharma Private Limited. The label includes storage instructions (20°C to 25°C), pharmacist dispensing guidance, prescription-only status, and packaging of 30 capsules. Manufacturer address in Telangana, India, and U.S. contact number are also shown.*

FDA Label Image

Venlafaxinecap37-5mgblistercarton (Venlafaxinecap37 5mgblistercarton)

Packaging label for Venlafaxine Hydrochloride Extended-Release Capsules USP 37.5 mg. The label indicates a unit-dose capsule oral formulation supplied in a 100 (10 x 10) count package. Manufactured by Annora Pharma Private Limited. The label includes storage instructions, pharmacist dispensing guidance, and a U.S. contact number.*

FDA Label Image

Venlafaxinecap37-5mgcontlabel30s (Venlafaxinecap37 5mgcontlabel30s)

Label for Venlafaxine Hydrochloride Extended-Release Capsules USP 37.5 mg, oral capsule extended release dosage form, manufactured by Annora Pharma Private Limited. The package contains 30 capsules. The label includes storage instructions at controlled room temperature and dispensing details. The NDC number is 71785-1006-0.*

FDA Label Image

Venlafaxinecap75mgblistercarton (Venlafaxinecap75mgblistercarton)

Box packaging label for Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, manufactured by Annora Pharma Private Limited. The label indicates the product contains 100 (10 x 10) unit-dose capsules, is for prescription use only (Rx only), and includes storage instructions and a U.S. contact number. The NDC is 71785-1007-3.*

FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

Chemical structure diagram of venlafaxine hydrochloride showing its molecular configuration including a chiral center. The structure highlights the arrangement of atoms and functional groups in the molecule.*

FDA Label Image

Venlafxinecap75mg30scontlabel (Venlafxinecap75mg30scontlabel)

Label for Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg. The label indicates a package containing 30 capsules, dispensing information, storage instructions, manufacturer Annora Pharma Private Limited, and a U.S. contact number. The label highlights that the medication is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.